Pentoxifylline

Epilepsy

Mostafa BahaaSmall moleculePhase 2Active

CCC

51/ 100

Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence: 38/ 100
Competitive Position: 73/ 100

Competitive context

76 Active assets in the Epilepsy cohort.

Asset / Sponsor	Phase	Rating
Topamax SK Life Science, Inc.	Phase 4	BBB
Eslicarbazepine Acetate Bial - Portela C S.A.	Phase 4	BBB
Lacosamide Second Affiliated Hospital of Guangzhou Medical University	Phase 4	BBB
LAMOTRIGINE Assiut University	Phase 4	BBB
Keppra Beijing Tiantan Hospital	Phase 4	BBB

View all 50 →

Same molecule, other indications

Pentoxifylline is also rated in:

metabolic dysfunction-associated steatohepatitisDormant

BBB

Indicative ·

76 / 100

Neuralgia PeripheralDormant

BB

Indicative ·

69 / 100

type 2 diabetes mellitusDormant

BB

Indicative ·

68 / 100

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.